Literature DB >> 3156839

Advantages and disadvantages of an in-vitro model with two compartments connected by a dialyser: results of experiments with ciprofloxacin.

D S Reeves.   

Abstract

A two-compartment in-vitro model is described in which the compartments are separated by a hollow-fibre dialyser. It was used successfully to simulate the 2-compartment kinetics of intravenously administered ciprofloxacin and to observe the activity of ciprofloxacin against a strain of Serratia marcescens growing in the peripheral compartment. Because of the complexity of the apparatus, however, the experiments were labour-intensive, prone to break-down, and gave results only slowly. There was a possibility that drug-resistant variants were carried over from one experiment to the next by re-use of the dialyser. While the model could give very flexible kinetics and retained all of the culture, there were constraints on the variations in kinetics from the physical sizes of the compartments and practicable flow rates. An ever-present problem was the possibility of fluid diafiltering rapidly into either compartment. Such a model should perhaps only be used when a very short drug half-life is to be simulated or very flexible kinetics required. Simpler, multi-channel equipment could be more productive.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3156839     DOI: 10.1093/jac/15.suppl_a.159

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  5 in total

Review 1.  Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials.

Authors:  R C Li; M Zhu; J J Schentag
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

Review 2.  Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC.

Authors:  Markus Mueller; Amparo de la Peña; Hartmut Derendorf
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

3.  Pharmacodynamic effects of sub-MICs of benzylpenicillin against Streptococcus pyogenes in a newly developed in vitro kinetic model.

Authors:  E Löwdin; I Odenholt; S Bengtsson; O Cars
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

Review 4.  In vitro pharmacokinetic/pharmacodynamic models in anti-infective drug development: focus on TB.

Authors:  Pavan K Vaddady; Richard E Lee; Bernd Meibohm
Journal:  Future Med Chem       Date:  2010-08       Impact factor: 3.808

5.  In vitro studies of pharmacodynamic properties of vancomycin against Staphylococcus aureus and Staphylococcus epidermidis.

Authors:  E Löwdin; I Odenholt; O Cars
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.